Cargando…
Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer
Cancer stem cells (CSCs) are responsible for aggressive tumor growth, metastasis and therapy resistance. In this study, we evaluated the effects of Shikonin (Shk) on breast cancer and found its anti-CSC potential. Shk treatment decreased the expression of various epithelial to mesenchymal transition...
Autores principales: | Thakur, Ravi, Trivedi, Rachana, Rastogi, Namrata, Singh, Manisha, Mishra, Durga Prasad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431480/ https://www.ncbi.nlm.nih.gov/pubmed/25973915 http://dx.doi.org/10.1038/srep10194 |
Ejemplares similares
-
Desmoglein 3 contributes to tumorigenicity of pancreatic ductal adenocarcinoma through activating Src–FAK signaling
por: Abula, Yimamumaimaitijiang, et al.
Publicado: (2021) -
Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
por: Trivedi, Rachana, et al.
Publicado: (2015) -
Therapeutic targeting of cancer cell cycle using proteasome inhibitors
por: Rastogi, Namrata, et al.
Publicado: (2012) -
Integrin β5 contributes to the tumorigenic potential of breast cancer cells through Src-FAK and MEK-ERK signaling pathways
por: Bianchi-Smiraglia, Anna, et al.
Publicado: (2012) -
FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling Pathway
por: Yeo, Mei Shi, et al.
Publicado: (2019)